Last reviewed · How we verify

NCT05838820

Hand Function Tests in Carpal Tunnel Syndrome: A Cross-sectional Study

Status unknown Last updated 3 May 2023
What this trial tests

trial testing Nine-Hole Peg Test in Carpal Tunnel Syndrome in 50 participants. Status unknown.

Timeline
18 May 2023
Primary endpoint
27 September 2023
1 October 2023

Quick facts

Lead sponsorAhram Canadian University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date18 May 2023
Primary completion27 September 2023
Estimated completion1 October 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ahram Canadian University

Who can join

Adults 18 to 60, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-sectional study that aims to establish the test-retest reliability of two standardized tests (Jebsen-Taylor Hand Function Test and Nine-Hole Peg Test) in individuals with carpal tunnel syndrome (CTS). The study will involve at least 50 participants with CTS who will complete the tests twice, with a 1-week interval between the two assessments. The test-retest reliability will be assessed using intraclass correlation coefficient (ICC) and Bland-Altman plots. The study is expected to provide information on the reliability of these tests in individuals with CTS, which can help clinicians more accurately assess hand function and monitor treatment outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Ahram Canadian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05838820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing